Your browser is no longer supported. Please, upgrade your browser.
Settings
ANGO [NASD]
AngioDynamics, Inc.
Index- P/E- EPS (ttm)-0.89 Insider Own2.60% Shs Outstand38.73M Perf Week-5.80%
Market Cap1.00B Forward P/E165.42 EPS next Y0.15 Insider Trans-2.52% Shs Float36.88M Perf Month-17.00%
Income-34.30M PEG- EPS next Q0.04 Inst Own95.10% Short Float1.44% Perf Quarter-9.75%
Sales297.80M P/S3.37 EPS this Y81.30% Inst Trans-2.47% Short Ratio2.29 Perf Half Y6.79%
Book/sh11.25 P/B2.28 EPS next Y761.11% ROA-6.00% Target Price34.50 Perf Year81.33%
Cash/sh0.91 P/C28.24 EPS next 5Y15.00% ROE-7.70% 52W Range13.72 - 32.00 Perf YTD67.25%
Dividend- P/FCF61.88 EPS past 5Y7.40% ROI-6.70% 52W High-19.88% Beta0.86
Dividend %- Quick Ratio1.60 Sales past 5Y-3.80% Gross Margin54.10% 52W Low86.88% ATR1.23
Employees800 Current Ratio2.50 Sales Q/Q9.70% Oper. Margin-12.80% RSI (14)35.25 Volatility6.90% 4.33%
OptionableYes Debt/Eq0.06 EPS Q/Q-60.90% Profit Margin-11.50% Rel Volume0.90 Prev Close26.55
ShortableYes LT Debt/Eq0.06 EarningsSep 30 BMO Payout- Avg Volume231.80K Price25.64
Recom2.50 SMA20-10.54% SMA50-7.20% SMA2000.37% Volume208,765 Change-3.43%
Oct-15-21Upgrade Canaccord Genuity Hold → Buy $28 → $37
Aug-20-21Initiated Oppenheimer Perform
Nov-25-20Upgrade Raymond James Mkt Perform → Strong Buy $18
Apr-08-20Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Apr-01-19Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Apr-03-18Upgrade Raymond James Mkt Perform → Outperform
Jan-05-18Downgrade Craig Hallum Buy → Hold
Apr-07-17Reiterated Cantor Fitzgerald Overweight $20 → $21
Mar-30-17Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
Feb-08-17Initiated Barclays Equal Weight $17
Nov-04-16Initiated Cantor Fitzgerald Buy
Apr-08-16Resumed Piper Jaffray Neutral
Jan-08-16Reiterated Canaccord Genuity Buy $17.50 → $14.50
Nov-10-15Downgrade Raymond James Outperform → Mkt Perform
Jul-24-15Initiated KeyBanc Capital Mkts Overweight
Jun-19-14Upgrade Canaccord Genuity Hold → Buy $16.25 → $20
Oct-09-12Reiterated Canaccord Genuity Hold $14 → $13.50
Jun-25-12Downgrade Canaccord Genuity Buy → Hold $16.50 → $14.50
Jul-15-11Upgrade Stifel Nicolaus Hold → Buy $16.50
Jul-15-11Upgrade Canaccord Genuity Hold → Buy $15 → $16.50
Nov-29-21 11:15AM  
Nov-26-21 02:21PM  
07:26AM  
Nov-25-21 07:55AM  
Nov-24-21 09:40AM  
Nov-18-21 10:31AM  
Nov-16-21 11:04AM  
Nov-12-21 09:36AM  
Nov-11-21 10:48AM  
Nov-10-21 07:32AM  
Nov-09-21 09:54AM  
Nov-08-21 10:18AM  
10:16AM  
Nov-05-21 10:34AM  
10:32AM  
Nov-04-21 07:55AM  
07:44AM  
06:40AM  
Nov-03-21 10:26AM  
10:24AM  
07:05AM  
Nov-02-21 12:51PM  
10:16AM  
Nov-01-21 11:45AM  
09:12AM  
Oct-29-21 01:03PM  
12:45PM  
10:39AM  
10:36AM  
10:33AM  
10:27AM  
Oct-28-21 06:13AM  
Oct-25-21 01:31PM  
Oct-07-21 11:16AM  
Oct-01-21 11:06AM  
Sep-30-21 01:44PM  
12:00PM  
07:00AM  
Sep-15-21 04:01PM  
Aug-12-21 11:30AM  
Jul-29-21 04:01PM  
Jul-18-21 06:21AM  
Jul-14-21 09:21AM  
Jul-13-21 12:30PM  
07:53AM  
07:00AM  
Jul-08-21 06:30PM  
Jun-24-21 04:01PM  
Jun-22-21 11:22AM  
Jun-09-21 09:19AM  
Jun-08-21 07:00AM  
Jun-01-21 04:01PM  
May-25-21 01:27AM  
May-17-21 04:01PM  
Apr-29-21 11:30AM  
Apr-20-21 12:05PM  
Apr-12-21 08:27AM  
06:00AM  
Apr-05-21 04:01PM  
Mar-31-21 12:59PM  
10:35AM  
04:30AM  
Mar-30-21 11:30AM  
08:15AM  
07:00AM  
06:15AM  
Mar-29-21 10:08AM  
Mar-23-21 12:30PM  
Mar-15-21 04:01PM  
Mar-10-21 08:29AM  
Mar-09-21 04:01PM  
08:00AM  
Mar-05-21 09:04AM  
Mar-04-21 11:06AM  
Mar-03-21 12:42PM  
09:35AM  
Mar-01-21 04:01PM  
11:15AM  
11:11AM  
Feb-26-21 09:26AM  
09:22AM  
09:01AM  
Feb-23-21 11:16PM  
Feb-12-21 11:47AM  
10:38AM  
Feb-11-21 12:24PM  
10:35AM  
09:11AM  
Feb-10-21 11:31AM  
10:18AM  
Feb-09-21 09:59AM  
Feb-08-21 09:14AM  
Feb-06-21 11:30AM  
Feb-05-21 11:09AM  
09:50AM  
06:00AM  
Feb-04-21 12:25PM  
11:25AM  
09:30AM  
09:29AM  
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides vascular interventions and therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Helsel DaveSVP Global Operations and R&DOct 20Sale27.973,49497,72726,387Oct 21 04:50 PM
Centea ScottSr. VP/GM, Global VITOct 15Option Exercise16.7712,000201,24058,244Oct 18 04:45 PM
Centea ScottSr. VP/GM, Global VITOct 15Sale27.9212,000335,04046,244Oct 18 04:45 PM
Campbell Chad ThomasSVP/GM, Vascular AccessOct 05Option Exercise16.5910,748178,30942,489Oct 06 06:39 PM
Campbell Chad ThomasSVP/GM, Vascular AccessOct 05Sale27.1510,748291,80831,741Oct 06 06:39 PM
Helsel DaveSVP Global Operations and R&DAug 12Option Exercise0.002,685024,507Aug 17 06:50 AM
Clemmer James CPresident and CEOAug 12Option Exercise0.0019,3870378,554Aug 17 06:49 AM
Campbell Chad ThomasSVP/GM, Vascular AccessAug 12Option Exercise0.002,395029,056Aug 17 06:48 AM
Trowbridge Stephen AEVP and CFOAug 12Option Exercise0.003,231071,539Aug 17 06:23 AM
Meteny Dennis SDirectorJul 28Option Exercise14.645,72683,829117,865Jul 30 06:31 PM
JOHNSON WESLEYDirectorJul 28Option Exercise14.645,72683,82989,375Jul 30 06:27 PM
Trowbridge Stephen AEVP and CFOApr 15Option Exercise14.0713,625191,70473,371Apr 16 05:39 PM
Helsel DaveSVP Global Operations and R&DApr 14Sale23.933,50083,75519,115Apr 15 04:20 PM
DONNELLY HOWARD WDirectorApr 01Option Exercise14.645,72683,82996,595Apr 05 05:53 PM
JOHNSON WESLEYDirectorJan 20Sale18.536,500120,44577,911Jan 21 10:15 AM